v3.26.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 228,363 $ 240,634
Marketable securities 561,969 494,450
Restricted cash 0 10,876
Accounts receivable 23,312 106,446
Inventory 11,458 11,545
Prepaid expenses and other current assets 25,714 26,815
Assets held for sale 0 87,510
Total current assets 850,816 978,276
Property and equipment, net 42,149 44,800
Right-of-use asset, net 21,358 22,897
Goodwill 112,888 113,462
Other non-current assets 15,951 17,077
Total assets 1,043,162 1,176,512
Current liabilities:    
Accounts payable 16,101 24,578
Accrued expenses 103,027 107,165
Deferred revenue 88,772 140,053
Current portion of finance lease liabilities 2,112 2,507
Other current liabilities 132,449 137,778
Liabilities held for sale 0 47,869
Total current liabilities 342,461 459,950
Deferred revenue 359,273 358,943
Long-term debt 291,039 244,213
Non-current finance lease liabilities 1,907 2,091
Other non-current liabilities 193,244 239,068
Total liabilities 1,187,924 1,304,265
Commitments and contingencies (Note 15)
Preferred stock, $0.01 par value, 2,000,000 shares authorized at March 31, 2026 and December 31, 2025; no shares issued and outstanding at March 31, 2026 and December 31, 2025 0 0
Stockholders' deficit:    
Common stock, $0.01 par value, 600,000,000 shares authorized at March 31, 2026 and December 31, 2025; 167,765,721 shares issued and 164,422,575 shares outstanding at March 31, 2026 and 164,969,773 shares issued and 162,575,937 shares outstanding at December 31, 2025 1,678 1,650
Additional paid-in capital 4,548,592 4,539,756
Accumulated deficit (4,577,639) (4,568,148)
Treasury stock, cost basis, 3,343,146 shares at March 31, 2026 and 2,393,836 shares at December 31, 2025 (112,319) (103,021)
Accumulated other comprehensive income (loss) (5,074) 2,010
Total stockholders’ deficit (144,762) (127,753)
Total liabilities and stockholders’ deficit $ 1,043,162 $ 1,176,512